Targeting p300 HAT Activity as a Novel Anticancer Strategy

Rhoda M. Alani, M.D., Herbert Mescon Professor and Chair, Department of Dermatology, Boston University School of Medicine; Dermatologist-in-Chief, Boston Medical Center, will present her seminar "Targeting p300 HAT Activity as a Novel Anticancer Strategy."

When 2:00 pm to 3:20 pm on Wednesday, April 10, 2013
Location R-115
Contact Name Christina Cherel